Skip to main content


Icon Legend

  • Thursday, Nov 21st
    10:15 AM – 11:45 AM PST
    Strategies and Challenges of Measurable Residual Disease Testing in Acute Myeloid Leukemia
    Location: 109 & 110, Level 1
    Program Committee Moderator: Amir Behdad, MD, MBA (he/him/his) – Cleveland Clinic Florida
    Co-Moderator (Early Career): Bing Melody Zhang, MD (she/her/hers) – Stanford University School of Medicine
    Oncology
     CE Credit: 1.5
  • Thursday, Nov 21st
    10:15 AM – 11:45 AM PST
    Unveiling Viral Associations in Human Cancer Using Genomic Data
    Location: 211 - 214, Level 2
    Program Committee Moderator: Arivarasan Karunamurthy, MD (he/him/his) – University of Pittsburgh Medical Center
    Co-Moderator (Early Career): Parsa Hodjat, MD (he/him/his) – Cincinnati Children's Hospital Medical Center
    OncologyInformatics
     CE Credit: 1.5
  • Thursday, Nov 21st
    10:15 AM – 11:00 AM PST
    Quantification of Measurable Residual Disease in Adults with Acute Myeloid Leukemia
    Location: 109 & 110, Level 1
    Breakout Speaker: Christopher S. Hourigan, DM DPhil (he/him/his) – Virginia Tech FBRI Cancer Research Center
    Oncology
     CE Credit: 1.5
  • Thursday, Nov 21st
    10:15 AM – 11:45 AM PST
    Mechanisms of Viral-Host Cell Interaction: Integration, Mutagenesis and Tumorigenesis
    Location: 211 - 214, Level 2
    Breakout Speaker: Gabriel J. Starrett, PhD (he/him/his) – National Cancer Institute
    OncologyInformatics
     CE Credit: 1.5
  • Thursday, Nov 21st
    10:15 AM – 11:45 AM PST
    Microbiome Discovery and Characterization from Next Generation Sequencing Data
    Location: 211 - 214, Level 2
    Breakout Speaker: Chad Vanderbilt, MD – Memorial Sloan Kettering Cancer Center
    OncologyInformatics
     CE Credit: 1.5
  • Thursday, Nov 21st
    11:00 AM – 11:45 AM PST
    AML MRD Analysis Using FLT3-ITD
    Location: 109 & 110, Level 1
    Breakout Speaker: Mark Levis, MD PhD – Johns Hopkins
    Oncology
     CE Credit: 1.5
  • Thursday, Nov 21st
    2:30 PM – 3:30 PM PST
    Continuing Challenges to Providing More Provider and Patient Friendly NGS Molecular Biomarker Reporting
    Location: 220 - 222, Level 2
    Working Group Moderator: Anthony Snow, MD – University of Iowa Hospitals and Clinics
    Lab ManagementOncology
  • Thursday, Nov 21st
    2:30 PM – 3:30 PM PST
    Continuing Challenges to Providing More Provider and Patient Friendly NGS Molecular Biomarker Reporting
    Location: 220 - 222, Level 2
    Working Group Speaker: Jane Gibson, PhD (she/her/hers) – Univ of Central Florida College of Medicine
    Panelist: Jennifer Laudadio, MD (she/her/hers) – University of Arkansas for Medical Sciences
    Lab ManagementOncology
  • Thursday, Nov 21st
    5:00 PM – 6:00 PM PST
    New Molecular Genomic Discoveries in B-Cell Neoplasms and Clinical Applications
    Location: Ballroom, Level 1
    Program Committee Moderator: Amir Behdad, MD, MBA (he/him/his) – Cleveland Clinic Florida
    Program Committee Moderator: Craig Soderquist, MD – Columbia University
    Oncology
     CE Credit: 1.5
  • Thursday, Nov 21st
    5:00 PM – 6:00 PM PST
    Novel Mechanisms of Lymphomagenesis and Transformation From Functional Proteogenomics
    Location: Ballroom, Level 1
    Plenary Speaker: Kojo Elenitoba-Johnson, MD (he/him/his) – Memorial Sloan Kettering Cancer Center
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    10:15 AM – 11:45 AM PST
    Bridging the Dimensions: Unleashing the Power of Deep Learning in Precision Medicine
    Location: 220 - 222, Level 2
    Program Committee Moderator: Heather Blankenship, PhD – Michigan Department of Health and Human Services
    Co-Moderator (Early Career): Shrey Sukhadia, PhD (he/him/his) – DHMC
    OncologyInformatics
     CE Credit: 1.5
  • Friday, Nov 22nd
    10:15 AM – 11:45 AM PST
    Utilization of Cell Free DNA in Characterization and Detection of Minimal Residual Disease in Lymphoid Malignancies
    Location: 118 - 120, Level 1
    Program Committee Moderator: Craig Soderquist, MD – Columbia University
    Co-Moderator (Early Career): Zejuan Li, MD, PhD, FACMG – Houston Methodist Hospital
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    10:15 AM – 11:00 AM PST
    Exploring Multimodal Deep Learning: Integrating Diverse Data for Enhanced Insights
    Location: 220 - 222, Level 2
    Breakout Speaker: Faisal Mahmood, Ph.D. – Brigham and Women's Hospital
    OncologyInformatics
     CE Credit: 1.5
  • Friday, Nov 22nd
    10:15 AM – 11:00 AM PST
    cfDNA in Early Detection of Hematologic malignancies
    Location: 118 - 120, Level 1
    Breakout Speaker: Rita Shaknovich, MD, PhD – Shaknovich Consulting LLC
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    11:00 AM – 11:45 AM PST
    Advancing Genomic Medicine: Leveraging Large Language Models and Polygenic Risk Scores in Clinical Practice
    Location: 220 - 222, Level 2
    Breakout Speaker: Cong Liu, PhD (he/him/his) – Boston Children's Hospital
    OncologyInformatics
     CE Credit: 1.5
  • Friday, Nov 22nd
    11:00 AM – 11:45 AM PST
    Profiling Cell-Free DNA in Lymphoma: MRD and Beyond
    Location: 118 - 120, Level 1
    Breakout Speaker: Brian Sworder, MD, PhD (he/him/his) – University of California, Irvine
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    1:15 PM – 2:45 PM PST
    AMP Clinical Bioinformatician Body of Knowledge
    Location: 211 - 214, Level 2
    Breakout Moderator: Weiwei Zhang, PhD – University of Nebraska Medical Center
    Lab ManagementOncologyInfectious DiseasesInformaticsInherited Conditions
  • Friday, Nov 22nd
    1:15 PM – 2:45 PM PST
    Whole Exome Sequencing in Solid Tumors - the Changing Paradigm of Clinical Oncology
    Location: 220 - 222, Level 2
    Program Committee Moderator: Deepika Sirohi, MD – University of California San Francisco
    Co-Moderator (Early Career): John M. Skaugen, MD (he/him/his) – University of Pittsburgh School of Medicine
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    1:15 PM – 2:00 PM PST
    Clinical Cancer Whole Exome and Transcriptome Sequencing: Lessons learned over 10 years and future outlook
    Location: 220 - 222, Level 2
    Breakout Speaker: Susan Hsiao, MD, PhD – Columbia University Irving Medical Center
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    1:15 PM – 2:45 PM PST
    AMP Clinical Bioinformatician Body of Knowledge
    Location: 211 - 214, Level 2
    Breakout Speaker: Somak Roy, MD – Cinncinnati Children's Hospital Medical Center
    Breakout Speaker: Annette Leon, PhD, MS, FACMG – Fabric Genomics
    Panelist: Sabah Kadri, PhD – Lurie Children's Hospital of Chicago
    Panelist: Ryan J. Schmidt, MD, PhD – Children's Hospital Los Angeles/Keck School of Medicine of USC
    Lab ManagementOncologyInfectious DiseasesInformaticsInherited Conditions
  • Friday, Nov 22nd
    2:00 PM – 2:45 PM PST
    Clinical Validation and Implementation of Somatic Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) for Solid Tumors and Hematopoietic Neoplasms.
    Location: 220 - 222, Level 2
    Breakout Speaker: Laura Tafe, MD (she/her/hers) – Dartmouth-Hitchcock Medical Center
    Oncology
     CE Credit: 1.5
  • Friday, Nov 22nd
    3:45 PM – 4:45 PM PST
    Human Tumor Atlas Network: Mapping Tumor Transitions at Molecular Resolution
    Location: Ballroom, Level 1
    Program Committee Moderator: Arivarasan Karunamurthy, MD (he/him/his) – University of Pittsburgh Medical Center
    Program Committee Moderator: Deepika Sirohi, MD – University of California San Francisco
    Oncology
     CE Credit: 1.0
  • Friday, Nov 22nd
    3:45 PM – 4:45 PM PST
    Human Tumor Atlas Network: Mapping Tumor Transitions at Molecular Resolution
    Location: Ballroom, Level 1
    Plenary Speaker: Peter K. Sorger, PhD (he/him/his) – Harvard Medical School
    Oncology
     CE Credit: 1.0
  • Saturday, Nov 23rd
    10:15 AM – 11:45 AM PST
    Advances in Characterizing Structural Chromosomal Alterations: Utility of Optical Genome Mapping and Long Read Sequencing in Hematopoietic Cancers and the Germline Genome
    Location: 109 & 110, Level 1
    Program Committee Moderator: Craig Soderquist, MD – Columbia University
    Program Committee Moderator: Honey Reddi, PhD, FACMG (she/her/hers) – Belay Diagnostics
    Co-Moderator (Early Career): Eric McGinnis, MD (he/him/his) – Vancouver General Hospital / University of British Columbia
    Oncology
     CE Credit: 1.5
  • Saturday, Nov 23rd
    10:15 AM – 11:45 AM PST
    Navigating the Landscape of Open Source Tools for Applications in Molecular Pathology
    Location: 220 - 222, Level 2
    Program Committee Moderator: Heather Blankenship, PhD – Michigan Department of Health and Human Services
    Co-Moderator (Early Career): Wesley Goar, PhD (he/him/his) – Nationwide Children's Hospital
    OncologyInfectious DiseasesInformatics
     CE Credit: 1.5
  • Saturday, Nov 23rd
    10:15 AM – 11:45 AM PST
    Radiogenomics: Integrating Molecular and Imaging Data in Cancer Diagnosis
    Location: 118 - 120, Level 1
    Program Committee Moderator: Arivarasan Karunamurthy, MD (he/him/his) – University of Pittsburgh Medical Center
    Co-Moderator (Early Career): Catherine Gestrich, D.O. – UPMC Children's Hospital of Pittsburgh
    Oncology
     CE Credit: 1.5
  • Saturday, Nov 23rd
    10:15 AM – 11:00 AM PST
    Developing Open-Source Bioinformatics Pipelines and Packages for Molecular Pathology
    Location: 220 - 222, Level 2
    Breakout Speaker: Malachi Griffith, PhD (he/him/his) – Washington University
    OncologyInfectious DiseasesInformatics
     CE Credit: 1.5
  • Saturday, Nov 23rd
    10:15 AM – 11:00 AM PST
    Optical Genome Mapping - A New Age in Cytogenetics
    Location: 109 & 110, Level 1
    Breakout Speaker: Brynn Levy, MSc(Med), PhD (he/him/his) – Columbia University
    Oncology
     CE Credit: 1.5
  • Saturday, Nov 23rd
    10:15 AM – 11:00 AM PST
    Radiogenomics: Integrating Molecular and Imaging Data in Cancer Diagnosis & Treatment
    Location: 118 - 120, Level 1
    Breakout Speaker: Robert Lo Gullo, MD (he/him/his) – Columbia university
    Oncology
     CE Credit: 1.5
  • Saturday, Nov 23rd
    11:00 AM – 11:45 AM PST
    Open-Source Bioinformatics Pipelines and Packages for Infectious Diseases
    Location: 220 - 222, Level 2
    Breakout Speaker: Robert A. Petit, III, PhD – State of Wyoming
    OncologyInfectious DiseasesInformatics
     CE Credit: 1.5
  • Saturday, Nov 23rd
    11:00 AM – 11:45 AM PST
    Radiogenomics: Integrating Molecular and Imaging Data in Cancer Diagnosis
    Location: 118 - 120, Level 1
    Breakout Speaker: Vinay Duddalwar, MD, FRCR – USC Keck School of Medicine
    Oncology
     CE Credit: 1.5
  • Saturday, Nov 23rd
    11:00 AM – 11:45 AM PST
    Long Read Sequencing: The Long and Short of It.
    Location: 109 & 110, Level 1
    Breakout Speaker: Fritz Sedlazeck, Baylor College of Medicine – Baylor College of Medicine
    Oncology
     CE Credit: 1.5
  • Saturday, Nov 23rd
    1:15 PM – 2:15 PM PST
    2024 CAP/IASLC/AMP Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline Update
    Location: 301 - 305, Level 3
    Working Group Moderator: Susan Hsiao, MD, PhD – Columbia University Irving Medical Center
    Oncology
  • Saturday, Nov 23rd
    1:15 PM – 2:15 PM PST
    AMP/ACMG/CPIC/CAP/DPWG/ESPT/PharmGKB/PharmVar DPYD Genotyping Recommendations
    Location: 220 - 222, Level 2
    Working Group Moderator: Stuart A. Scott, PhD – Stanford
    OncologyInherited Conditions
  • Saturday, Nov 23rd
    1:15 PM – 2:15 PM PST
    2024 CAP/IASLC/AMP Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline Update
    Location: 301 - 305, Level 3
    Working Group Speaker: Dhananjay A. Chitale, MD, MBA (he/him/his) – Henry Ford Health
    Oncology
  • Saturday, Nov 23rd
    1:15 PM – 2:15 PM PST
    AMP/ACMG/CPIC/CAP/DPWG/ESPT/PharmGKB/PharmVar DPYD Genotyping Recommendations
    Location: 220 - 222, Level 2
    Working Group Speaker: Yuan Ji, MS, PhD, MBA (she/her/hers) – University of Utah
    Panelist: Lisa V. Kalman, PhD – Centers for Disease Control and Prevention
    OncologyInherited Conditions
  • Saturday, Nov 23rd
    2:30 PM – 4:00 PM PST
    Role of Gender Identification in Genetic Testing
    Location: 109 & 110, Level 1
    Program Committee Moderator: Stuart A. Scott, PhD – Stanford
    Co-Moderator (Early Career): Stephanie Siegmund, MD PhD (she/her/hers) – Harvard Medical School / Brigham & Women's Hospital
    AdvocacyLab ManagementOncologyInherited Conditions
     CE Credit: NOT CME/CMLE
  • Saturday, Nov 23rd
    2:30 PM – 3:00 PM PST
    Sex and Gender in Medicine: The Basics
    Location: 109 & 110, Level 1
    Breakout Speaker: J9 Austin, PhD, CGC, FCAHS (they/them/theirs) – Departments of Psychiatry and Medical Genetics, University of British Columbia
    AdvocacyLab ManagementOncologyInherited Conditions
     CE Credit: NOT CME/CMLE
  • Saturday, Nov 23rd
    3:00 PM – 3:30 PM PST
    Role of Sex and Gender in Clinical Oncology and Medical Genetics
    Location: 109 & 110, Level 1
    Breakout Speaker: Gwendolyn Quinn, PhD (she/her/hers) – , NYU Grossman School of Medicine, New York City, NY, USA
    AdvocacyLab ManagementOncologyInherited Conditions
     CE Credit: 1.5
  • Saturday, Nov 23rd
    3:30 PM – 4:00 PM PST
    How Labs Can Be Allies: Why Language Matters for Testing Accuracy and Patient Experience
    Location: 109 & 110, Level 1
    Breakout Speaker: Margo Gallegos, MS, LCGC (she/her/hers) – Ambry Genetics
    AdvocacyLab ManagementOncologyInherited Conditions
     CE Credit: NOT CME/CMLE